Loading...
Market
Story
Study Finds mRNA COVID-19 Vaccine Linked to 60 Times Higher Heart Disease Risk; CDC Recommends 3 Doses for Infants 6 Months and Older
Oct 30, 2024, 11:12 AM
A recent peer-reviewed study indicates that individuals who received one dose of an mRNA COVID-19 vaccine have a higher risk of acute heart disease compared to those who received a non-mRNA vaccine. This finding raises concerns about the safety of mRNA vaccines, particularly in young males. Additionally, the FDA has been criticized for allegedly overestimating the benefit-risk ratio of the mRNA vaccine for males aged 18-25 by more than 60 times, based on new data regarding Omicron and myocarditis. The CDC's new guidelines recommend that infants aged 6 months and older receive three COVID-19 vaccinations, despite claims that there is insufficient scientific evidence demonstrating a reduction in hospitalizations or deaths. Critics argue that this recommendation may contribute to growing public distrust in health authorities, as the hospitalization and death rates from COVID-19 among infants and children are low. Furthermore, some experts suggest that natural immunity may be effective and that vaccines do not necessarily prevent the spread of the virus.
View original story
Similar markets
Supports Wuhan Market Theory • 25%
Supports Laboratory Leak Theory • 25%
Supports Other Animal Market Theory • 25%
Remains Uncertain • 25%
Yes, WHO • 25%
Yes, CDC • 25%
Yes, other • 25%
No • 25%
WHO • 25%
CDC • 25%
ECDC • 25%
Other • 25%
Yes • 50%
No • 50%
Support study's findings • 25%
Refute study's findings • 25%
Call for more research • 25%
No official stance • 25%
World Health Organization • 25%
Centers for Disease Control and Prevention • 25%
European Centre for Disease Prevention and Control • 25%
Other • 25%
Wuhan Market • 25%
Laboratory Leak • 25%
Other Animal Market • 25%
Other • 25%
Yes • 50%
No • 50%
Implement moratorium • 25%
Conduct further research • 25%
Ignore findings • 25%
Issue public warnings • 25%
Yes • 50%
No • 50%
